These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38948099)

  • 21. Wharton's Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury.
    Cheng T; Yang B; Li D; Ma S; Tian Y; Qu R; Zhang W; Zhang Y; Hu K; Guan F; Wang J
    Cell Mol Neurobiol; 2015 Jul; 35(5):641-9. PubMed ID: 25638565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
    Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
    Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.
    Liu X; Zheng P; Wang X; Dai G; Cheng H; Zhang Z; Hua R; Niu X; Shi J; An Y
    Stem Cell Res Ther; 2014 Apr; 5(2):57. PubMed ID: 24759263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
    Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
    J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
    Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
    Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up.
    Saleh M; Vaezi AA; Sohrabpour AA; Barkhordar M; Aghaghazvini L; Alijani N; Verdi J
    Gene Rep; 2022 Dec; 29():101691. PubMed ID: 36373143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Robust and Highly Efficient Approach for Isolation of Mesenchymal Stem Cells From Wharton's Jelly for Tissue Repair.
    Zheng S; Gao Y; Chen K; Liu Y; Xia N; Fang F
    Cell Transplant; 2022; 31():9636897221084354. PubMed ID: 35313748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury.
    Jamali F; Alqudah M; Rahmeh R; Bawaneh H; Al-Shudifat A; Samara O; Awidi A
    Am J Case Rep; 2023 May; 24():e938576. PubMed ID: 37177780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease.
    Cho JW; Park KS; Bae JY
    Regen Ther; 2019 Dec; 11():207-211. PubMed ID: 31489344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model.
    Xie ZH; Liu Z; Zhang XR; Yang H; Wei LF; Wang Y; Xu SL; Sun L; Lai C; Bi JZ; Wang XY
    Clin Exp Med; 2016 Feb; 16(1):89-98. PubMed ID: 26188488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.
    Yu HR; Huang HC; Chen IL; Li SC
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata.
    Czarnecka A; Odziomek A; Murzyn M; Dubis J; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
    Adv Clin Exp Med; 2021 Feb; 30(2):211-218. PubMed ID: 33636057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin Priming Promotes the Neuroprotective Effects of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Via the HGF/AKT/STAT3 Signaling Pathway.
    Ha GH; Yeon JY; Kim KH; Lee DM; Chae HY; Nam H; Lee K; Kim DO; Kim CK; Joo KM
    Stem Cells Dev; 2024 Feb; 33(3-4):89-103. PubMed ID: 38164089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of anti-fibrotic factors ameliorates anti-fibrotic properties of Wharton's jelly derived mesenchymal stem cells under oxidative damage.
    Nimsanor N; Phetfong J; Kitiyanant N; Kamprom W; Supokawej A
    Biosci Trends; 2019 Nov; 13(5):411-422. PubMed ID: 31656260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
    Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.
    Sabapathy V; Sundaram B; V M S; Mankuzhy P; Kumar S
    PLoS One; 2014; 9(4):e93726. PubMed ID: 24736473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.
    Özmert E; Arslan U
    Stem Cell Res Ther; 2020 Aug; 11(1):353. PubMed ID: 32787913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
    Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
    J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.